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Nerve growth factor (NGF) binding to its receptor TrkA, which belongs to the family of receptor tyro-
sine kinases (RTKs), is known to induce its internalization, endosomal trafﬁcking and subsequent
lysosomal degradation. The Cbl family of ubiquitin ligases plays a major role in mediating ubiquiti-
nation and degradation of RTKs. However, it is not known whether Cbl participates in mediating
ubiquitination of TrkA. Here we report that c-Cbl mediates ligand-induced ubiquitination and deg-
radation of TrkA. TrkA ubiquitination and degradation required direct interactions between c-Cbl
and phosphorylated TrkA. c-Cbl and ubiquitinated TrkA are found in a complex after NGF stimula-
tion and are degraded in lysosomes. Taken together, our data demonstrate that c-Cbl can induce
downregulation of NGF-TrkA complexes through ubiquitination and degradation of TrkA.
Structured summary of protein interactions:
TrkA physically interacts with c-Cbl by anti bait coimmunoprecipitation (View interaction)
c-Cbl physically interacts with TrkA by anti bait coimmunoprecipitation (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Protein tyrosine kinases are known to be implicated in the
majority of cellular functions, especially those involved in intracel-
lular signal transduction, whereas the deregulation of tyrosine ki-
nases is often associated with human diseases such as cancer
[1,2]. Binding of growth factors to receptor tyrosine kinases (RTKs)
promotes receptor dimerization and subsequent activation [3],
which enhances autophosphorylation of RTKs, phosphorylation of
numerous cellular proteins, and recruitment of adaptor molecules
and enzymes/kinases, which in turn initiate signaling cascades [1].
A major route of receptor internalization is via an elaborate clath-
rin-based machinery that assembles at the plasma membrane
within a few minutes after ligand stimulation [4]. Receptors are
subsequently internalized by clathrin-mediated endocytosis and
transferred into endosomal compartments from where they may
either be recycled back to the plasma membrane or sorted intochemical Societies. Published by E
tegrative Physiology, Gunma
wa-machi, Maebashi, Gunma
. Shimokawa).the intraluminal vesicles of multivesicular bodies (MVBs) [5] to be-
come targeted for lysosomal degradation [6].
Previous studies have implicated the protooncogene c-Cbl as a
negative regulator of RTKs [7]. Cbl is a RING type ubiquitin ligase
(E3) that promotes RTK ubiquitination which acts as a sorting sig-
nal for lysosomal receptor degradation. Many RTKs, such as hepa-
tocyte growth factor (HGF), epidermal growth factor (EGF) and
platelet-derived growth factor (PDGF) receptors, rapidly undergo
Cbl-mediated ubiquitination following their ligand binding, which
is required for their lysosomal degradation [8–10]. We have re-
ported that Cbl binds to activated EGF receptors to promote their
monoubiquitination at multiple sites followed by lysosomal degra-
dation of EGF receptors in complex with Cbl and endocytic proteins
[11,12].
Nerve growth factor (NGF) receptor TrkA is also a member of
the family of RTKs and belongs to a sub-family of protein kinases
which also includes TrkB and TrkC. TrkA regulates neuronal cell
proliferation and is important for development and maturation of
the nervous system [13]. It is known that ligand-induced activation
of TrkA induces its ubiquitination and subsequent degradation
[14], but ubiquitin ligases that mediate TrkA ubiquitination have
remained unknown until recently when Arévalo et al. [15]lsevier B.V. All rights reserved.
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ically to the C-terminus of TrkA and to induce receptor downregu-
lation. Nedd4-2 was originally found as an epithelial Na+ channel
(ENaC)-speciﬁc ubiquitin ligase [16,17]. Nedd4-2 controls ENaC
surface expression by catalyzing its ubiquitination, which targets
ENaC for degradation. This requires binding of Nedd4-2 to PPxY
motifs located in the cytoplasmic C-terminus of each ENaC subunit
(a, b and c). Nedd4-2 also binds to a PPxY motif in TrkA, which is
required for its ubiquitination and downregulation [15].
In this study, we show that c-Cbl can also promote ligand-in-
duced ubiquitination and consequent degradation of TrkA. After
NGF stimulation, TrkA is internalized from the cell surface within
a few minutes and becomes ubiquitinated by c-Cbl. Ubiquitinated
TrkA is degraded with c-Cbl in lysosomes. These results indicate
that ubiquitination and degradation of TrkA may be mediated by
different families of ubiquitin ligases and that TrkA, like many
other RTKs, is ubiquitinated by Cbl.
2. Materials and methods
2.1. Reagents and antibodies
Murine NGF 2.5S and MG132 were purchased from Promega
(Madison, WI) and Calbiochem (San Diego, CA), respectively.
K252a, a potent inhibitor of protein kinases, was purchased from
Wako Pure Chemicals (Osaka, Japan). Kanamycin sulfate, Dul-
becco’s modiﬁed Eagle’s medium (DMEM), fetal calf serum (FCS)
and horse serum (HS) were obtained from Life Technologies (Carls-
bad, CA). Rabbit polyclonal anti-Cbl (RF) was described previously
[9]. Rabbit polyclonal anti-TrkA (763) was purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). Rabbit polyclonal anti-Nedd4,
anti-phospho-TrkA (Tyr 490), anti-b-actin and mouse monoclonal
anti-ubiquitin (P4D1) antibodies were purchased Cell Signaling
Technology (Danvers, MA). Mouse monoclonal anti-ubiquitin anti-
body (Clone 6C1) was obtained from Sigma (St Louis, MO). Horse-
radish peroxidase (HRP)-conjugated donkey anti-rabbit IgG and
anti-mouse IgG were purchased from GE Healthcare (Buckingham-
shire, UK).
2.2. Plasmids
pRK5-TrkA was kindly gifted from Prof. Joseph Schlessinger
(Yale University). Constructs of pRK5-Cbl and FLAG-tagged ubiqui-
tin have been described [9]. A cDNA clone containing the full-
length of the human Nedd4-2 (GenBank accession no. NM
001144964) was provided from Kazusa DNA Research Institute
(Chiba, Japan) and its coding regions was cloned by PCR (forward:
50-GCCCAAGCTTACCATGGAGCGACCCTATACAT-30; reverse: 50-
GCCGCTCGAGATCCACCCCTTCAAATCCT-30). PCR fragments were
inserted into Hind III-Xho I sites of pcDNA3.0 vector (Life Technol-
ogies). The PCR fragment was veriﬁed by DNA sequencing. pSRa-
neo-Cbl-70Z and pSRaneo-Cbl-G306E were provided by Prof.
Wallace Y. Langdon (University of Western Australia).
2.3. Cell culture, transfections and stimulations
Human embryonic kidney (HEK) 293 cells and PC12 (a rat pheo-
chromocytoma tumor cell line) cells were provided by RIKEN Cell
Bank (Tsukuba, Japan) and cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 10% FCS (HEK 293) or with
10% heat-inactivated HS and 5% FCS (PC12) and kanamycin sulfate
(1 mg/ml). Cells were kept in a humid atmosphere with 5% CO2 at
37 C. Cells were transiently transfected 24 h following plating
with plasmids using Lipofectamine 2000 (Life Technologies) as de-
scribed in the manufacturer’s instructions. Thirty hours after trans-fection, cells were starved for 12 h in serum-free DMEM before
stimulation for the indicated times with 50 ng/ml NGF. The protea-
some inhibitor MG132 was used at a concentration of 20 lM for
60 min before NGF stimulation where indicated. The kinase inhib-
itor K252a was used at a concentration of 100 nM for 30 min be-
fore NGF stimulation where indicated [18].
2.4. Cell lysis, immunoprecipitation, SDS–PAGE and Western blot
Cells were lysed on ice in lysis buffer containing 10 mM Tris–
HCl pH 7.8, 150 mM NaCl, 1 mM EDTA, 1% (v/v) Nonidet P40, 1%
(w/v) sodium deoxycholate, protease inhibitors (10 mg/ml aproti-
nin, 2.5 mg/ml leupeptin, and 1 mM phenylmethylsulfonyl ﬂuo-
ride), and 1 mM sodium orthovanadate (a phosphatase inhibitor).
The lysates were cleared by centrifugation at 16000g for
20 min at 4 C and protein concentrations in the lysates were mea-
sured (Bradford protein assay, Bio-Rad, Hercules, CA).
For immunoprecipitation, equal amounts of cell lysates were
mixed with the indicated antibodies and incubated end-over-end
at 4 C for 90 min. Protein G Sepharose beads (GE Healthcare) were
added for 60 min and subsequently washed three times in ice-cold
lysis buffer. Proteins were eluted and denatured in Laemmli sam-
ple buffer containing 5% b-mercapto-ethanol, separated by SDS–
PAGE (7% polyacrylamide gels) and transferred to nitrocellulose
membrane (Hybond ECL, GE Healthcare). Membranes were
blocked in Tris-buffered saline with Tween 20 (TBS-T, 150 mM
NaCl, 20 mM Tris–HCl, pH 7.5, 0.1% Tween 20) and with 5% non-
fat dried milk overnight at 4 C. Immunoblotting was performed
with the indicated primary antibodies diluted in TBS-T with 5%
non-fat dried milk for 120 min at room temperature. After washing
in TBS-T for 30 min, membranes were incubated with anti-rabbit
IgG or anti-mouse IgG coupled to HRP in TBS-T with 5% non-fat
dried milk for 60 min at room temperature. The antibody-antigen
complexes were detected using the ECL system and visualized with
a Lumi-Imager imaging analyzer (Roche, Basel, Switzerland). The
intensity of bands was quantiﬁed using an image analysis software
(LumiAnalyst, Roche). In some cases, as indicated, blots were re-
probed with an anti-b-actin antibody (Santa Cruz Biotechnology)
for monitoring the quantity and integrity of protein.
2.5. TrkA biotinylation and internalization assay
Receptor biotinylation and internalization assays were per-
formed by the cleavable biotin method [19] and using a commer-
cial kit (Cell Surface Protein Isolation Kit, Pierce, Rockford, IL).
Cells transfected with TrkA and ubiquitin alone or together with
Nedd4-2 or c-Cbl were treated with NGF (50 ng/ml) for 0, 10 or
30 min. After ligand stimulation, cell surfaces were biotinylated
with 250 lg/ml cleavable Sulfo-NHS-SS-Biotin for 30 min at 4 C.
Cells were subsequently lysed with a detergent and disrupted by
sonication. A part of cell lysates were analyzed to monitor of the
expression levels of Nedd4-2 or c-Cbl. Biotin-labelled proteins
were isolated with NeutrAvidin agarose beads from the cell lysates.
The bound proteins were released by incubation with SDS–PAGE
sample buffer containing 50 mM DTT. Biotinylated proteins were
resolved by SDS–PAGE, transferred to a nitrocellulose ﬁlter and
immunoblotted with an anti-TrkA antibody (1:1000). TrkA was de-
tected by Western blotting as described above.
2.6. Statistical analysis
Results are expressed as the intensity relative to the control va-
lue, with mean ± S.E.M. The signiﬁcance of differences in intensity
of antibody-antigen complexes on Western blot was evaluated
using a Student’s t-test, with the level of signiﬁcance set at
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post hoc between group comparisons. The probability level taken
to indicate signiﬁcance was P < 0.05.
3. Results
3.1. c-Cbl causes degradation of TrkA
Nerve growth factor (NGF) binding induces TrkA dimerization,
autophosphorylation, and rapid endocytosis [20]. NGF binding also
induces ubiquitination and degradation of TrkA by a HECT type E3
ubiquitin ligase, Nedd4-2, that binds speciﬁcally to the C-terminus
of TrkA and induces the downregulation of the receptor [15]. Many
other RTKs also undergo degradation in lysosomes following their
ligand-induced activation [8–10]. This process is largely controlled
by ubiquitination of activated receptors by the c-Cbl RING type E3
ubiquitin ligase [7–10,12]. We therefore tested whether c-Cbl is in-
volved in TrkA downregulation. First, we conﬁrmed that Nedd4-2
promotes ligand-induced degradation of TrkA (Fig. 1A). NGF stim-
ulation led to a modest degradation of TrkA in HEK293 cells. After
overexpression of Nedd4-2, NGF-induced TrkA degradation was
signiﬁcantly promoted, as determined by quantiﬁcation of Wes-
tern blots from four independent experiments, a result that is con-
sistent with previous studies [15]. Co-overexpression of ubiquitin
promoted TrkA degradation even more strongly (Fig. 1A). Interest-
ingly, expression of c-Cbl also caused a marked degradation of TrkA
following NGF stimulation, and the degradation was further pro-
moted by co-expression with ubiquitin (Fig. 1B). It is well known
that PC12 cells express endogenous TrkA and that they differenti-
ate into a phenotype resembling sympathetic neurons in response
to NGF exposure [21]. To conﬁrm that c-Cbl promotes the degrada-
tion of endogenous TrkA, we analyzed NGF-induced TrkA degrada-
tion in PC12 cells. As shown in Fig. 1C, we conﬁrmed thatFig. 1. Nedd4-2 and c-Cbl promote ligand-induced degradation of TrkA. (A) Nedd4-2
transfected with expression vectors coding for TrkA with (+) or without () Nedd4-2 an
and mock-treated () or stimulated (+) with 50 ng/ml NGF for 60 min. (B) c-Cbl promote
with expression vectors coding for TrkA with (+) or without () c-Cbl and FLAG-tagged u
NGF-induced degradation of endogenous TrkA. PC12 cells were transiently transfected wi
and were stimulated with NGF as described for Fig. 1A. Representative immunoblots (upp
are shown. Cell lysates were analyzed for TrkA, Nedd4-2, c-Cbl, ubiquitin and b-actin le
equal loading. The differences between the amount of TrkA with or without NGF stimulat
n = 4.expression of c-Cbl caused a marked degradation of endogenous
TrkA in these cells following NGF stimulation. Quantiﬁcations
showed a marked decrease in the amount of TrkA after 60 min of
NGF stimulation (Fig. 2A) and with increasing concentrations of
c-Cbl (Fig. 2B), further conﬁrming the role of c-Cbl in mediating li-
gand-induced TrkA degradation.
3.2. c-Cbl and Nedd4-2 do not affect the internalization of TrkA
To determine the effect of c-Cbl and Nedd4-2 on TrkA internal-
ization, we performed biotinylation assays, allowing us to follow
the uptake of TrkA after NGF stimulation. After NGF stimulation
for 0, 10 and 30 min, the cell surface proteins were biotinylated
and precipitated using streptavidin-conjugated beads. When stim-
ulating the cultured cells with NGF for 10 min, cells transfected
with TrkA (control) rapidly decreased the levels of TrkA on the cell
surface by 40%, and then after 30 min of NGF stimulation, TrkA sur-
face levels had decreased by 60% (Fig. 3A, upper panel; Fig. 3B).
These values correspond with the results shown by a previous
report [22]. There was no difference in the average amount of
internalized TrkA following NGF stimulation upon expression of
Nedd4-2 or c-Cbl compared to the control (Fig. 3A, middle and low-
er panels; Fig. 3B). Thus, Nedd4-2 and c-Cbl have little effect on the
internalization of TrkA (Fig. 3A, middle and lower panels; Fig. 3B).
3.3. c-Cbl-mediated TrkA degradation requires ubiquitination of TrkA
by c-Cbl
Since TrkA binds directly to Nedd4-2 that promotes ubiquitina-
tion in an NGF-dependent manner [15], we next tested the poten-
tial of Cbl to ubiquitinate TrkA. NGF treatment of HEK293 cells
transfected with wild-type c-Cbl together with TrkA and ubiquitin
for 15 min led to ligand-induced ubiquitination of TrkA as shownpromotes degradation of TrkA in response to NGF. HEK293 cells were transiently
d FLAG-tagged ubiquitin. Thirty hours after transfection, cells were starved for 12 h
s degradation of TrkA in response to NGF. HEK293 cells were transiently transfected
biquitin, and were stimulated with NGF as described for Fig. 1A. (C) c-Cbl promotes
th (+) or without () expression vectors coding for c-Cbl and FLAG-tagged ubiquitin,
er panels) and quantiﬁcation (lower panels) of the amount of TrkA in cultured cells
vels by Western blotting with speciﬁc antibodies. b-actin was used as a control for
ion were analyzed by a Student’s t-test, with the level of signiﬁcance set at ⁄P < 0.05,
Fig. 2. c-Cbl is involved in the ligand-induced degradation of TrkA. (A) HEK293 cells
were transiently transfected with expression vectors coding for TrkA, c-Cbl (2 lg)
and FLAG-tagged ubiquitin. Thirty hours after transfection, cells were starved for
12 h and mock-treated () or stimulated with 50 ng/ml NGF for the indicated times
(min). Representative immunoblots (upper panel) and quantiﬁcation (lower panel)
of the amount of TrkA in cultured cells after NGF stimulation are shown. The
differences between the amount of TrkA with and without NGF stimulation were
analyzed by ANOVA and Duncan multiple range test for post hoc between group
comparisons, with the level of signiﬁcance set at ⁄P < 0.05, n = 4. Asterisks (⁄)
indicate a signiﬁcant difference relative to the value at mock-treated stimulation.
(B) HEK293 cells overexpressing TrkA, FLAG-tagged ubiquitin and the indicated
amount of c-Cbl were stimulated with NGF for 60 min. Representative immunoblots
(upper panel) and quantiﬁcation (lower panel) of the amount of TrkA in cultured
cells after NGF stimulation are shown. Cell lysates were analyzed for TrkA, c-Cbl,
ubiquitin and b-actin levels by Western blotting with speciﬁc antibodies. b-actin
was used as a control for equal loading. The differences between the amount of TrkA
with and without transfection of c-Cbl were analyzed by a Student’s t-test, with the
level of signiﬁcance set at ⁄P < 0.05, n = 4. Asterisks (⁄) indicate a signiﬁcant
difference relative to the value without transfection of c-Cbl.
Fig. 3. c-Cbl and Nedd4-2 do not affect the internalization of TrkA. Representative
immunoblots (A) and quantiﬁcation (B) of the amount of surface-associated TrkA in
cultured cells after NGF stimulation are shown. HEK293 cells were overexpressing
TrkA without or with Nedd4-2 or c-Cbl and treated with 50 ng/ml NGF for the
indicated times before biotinylation. After biotinylation, cells were subsequently
lysed with a detergent and disrupted by sonication. A part of cell lysates were
analyzed to monitor of the expression levels of Nedd4-2 or c-Cbl by Western
blotting with speciﬁc antibodies. The remaining cell surface proteins were
subsequently isolated with avidin and analyzed by Western blotting. The quanti-
ﬁcation of surface-associated TrkA after NGF stimulation is normalized to and
depicted as the reduction of band intensity as compared with non-stimulated cells
at the indicated times. The differences between control (cultured cells transfected
with TrkA and ubiquitin, O) and the other cultured cells (transfected with TrkA and
ubiquitin with Nedd4-2, or c-Cbl, ) were analyzed by ANOVA and Duncan
multiple range test for post hoc between group comparisons, with the level of
signiﬁcance set at ⁄P < 0.05, n = 3.
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against TrkA and ubiquitin. A ligase-deﬁcient mutant of Cbl (Cbl-
70Z), on the other hand, was impaired in the ability to ubiquitinate
TrkA (Fig. 4A, upper and lower panels). Furthermore, no effect was
observed on NGF-induced TrkA degradation when expressing Cbl-
70Z instead of wild-type c-Cbl (Fig. 4B). Therefore, ubiquitination
by c-Cbl may be critical for NGF-induced TrkA degradation.Importantly, c-Cbl was readily co-immunoprecipitated with TrkA
following NGF stimulation showing that c-Cbl and TrkA form a
complex following receptor activation (Fig. 4C).
3.4. TrkA is degraded together with c-Cbl in the lysosome
The above results indicated that Cbl may be critical for NGF-in-
duced ubiquitination and degradation of TrkA in mammalian cells.
We further analyzed whether these proteins are targeted for
destruction in the lysosome. Prolonged NGF stimulation of
HEK293 cells expressing TrkA, c-Cbl and ubiquitin led to a sus-
tained ubiquitination of TrkA and their degradation (Fig. 5A). Deg-
radation of c-Cbl was comparable with that of TrkA (Fig. 5A, also
shown in Fig. 4B). In addition, degradation of TrkA and c-Cbl was
sensitive to treatment with the proteasome inhibitor MG132
(Fig. 5B). MG132 was previously shown to act as a potent inhibitor
of lysosomal degradation of TrkA by blocking proteasomal activity
and the sorting of TrkA into multivesicular bodies (MVBs) [23]. In
MG132-treated cells, ubiquitinated TrkA seemed to accumulate
following NGF stimulation, and c-Cbl was not degraded (Fig. 5B).
This result indicates an involvement of the ubiquitin-proteasome
pathway in the lysosomal transport of TrkA.
Moreover, overexpression of Cbl-G306E, which is unable to
interact with phosphotyrosines of activated receptor tyrosine ki-
nases [24], neither induced signiﬁcant degradation of TrkA nor of
c-Cbl (Fig. 5C), suggesting that interactions between TrkA and Cbl
are critical for efﬁcient downregulation of TrkA. The phosphoryla-
Fig. 4. c-Cbl-mediated TrkA degradation requires ubiquitination of TrkA by c-Cbl. (A) HEK293 cells overexpressing TrkA, FLAG-tagged ubiquitin and c-Cbl, or Cbl-70Z (70Z)
were starved for 12 h and mock-treated () or stimulated (+) with 50 ng/ml NGF for 15 min. Levels of TrkA, c-Cbl and ubiquitin were determined in the total cell lysates (TCL)
(upper panel). Immunoprecipitates of TrkA were analyzed by Western blotting with an anti-ubiquitin antibody (lower panel). (B) HEK293 cells overexpressing TrkA, FLAG-
tagged ubiquitin and c-Cbl, or Cbl-70Z (70Z) were starved for 12 h and stimulated with 50 ng/ml NGF for 60 min. A representative immunoblot (upper panel) and a
quantiﬁcation (lower panel) of the amount of TrkA in cultured cells are shown. Cell lysates were analyzed for TrkA, c-Cbl, ubiquitin and b-actin levels by Western blotting
with speciﬁc antibodies. b-actin was used as a control for equal loading. The differences between the amount of TrkA with and without NGF stimulation were analyzed by a
Student’s t-test, with the level of signiﬁcance set at ⁄P < 0.05, n = 4. (C) Immunoprecipitations of the TrkA-c-Cbl complex. HEK293 cells overexpressing TrkA, c-Cbl and FLAG-
tagged ubiquitin were starved and mock-treated () or stimulated (+) with 50 ng/ml NGF for 30 min. TrkA and c-Cbl were co-immunoprecipitated following NGF stimulation
using either an anti-c-Cbl antibody (upper panel) or an anti-TrkA antibody (lower panel). The position of standard molecular masses (kDa) are indicated at the left.
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shown in Fig. 5D, HEK293 cells transfected TrkA, ubiquitin and c-
Cbl were pretreated with K252a, a tyrosine kinase inhibitor, or
its vehicle (0.1% DMSO) before adding NGF. After 20 min, the phos-
phorylation of TrkA was examined and K252a indeed blocked the
phosphorylation of TrkA (lower panel). After 60 min, presence of
K252a neither induced signiﬁcant degradation of TrkA nor of c-
Cbl (upper panel). Taken together, these data indicate that TrkA
and c-Cbl are degraded along the same pathway and suggest that
TrkA phosphorylation and ubiquitination are involved in control-
ling its downregulation. Whether a switching mechanism betweenNedd4-2 and c-Cbl in TrkA degradation exists as well as the bind-
ing sites of activated TrkA and c-Cbl remain to be determined.
4. Discussion
In the present study, we show that downregulation of TrkA is
induced by both the RING type ubiquitin ligase c-Cbl and the HECT
type ubiquitin ligase Nedd4-2. c-Cbl promotes ligand-induced deg-
radation of TrkA (Figs. 1 and 2), and the degradation requires the
phosphorylation of TrkA itself (Fig. 5D), the binding of Cbl to phos-
phorylated TrkA and TrkA ubiquitination by c-Cbl (Fig. 4). c-Cbl
Fig. 5. c-Cbl is degraded together with TrkA. HEK293 cells overexpressing TrkA,
FLAG-tagged ubiquitin and c-Cbl were starved and either mock-treated (A) or
treated for 60 min with 20 lm of the proteasome inhibitor MG132 (B) as indicated,
followed by mock treatment or NGF (50 ng/ml) stimulation for 60 min. (C) HEK293
cells overexpressing TrkA, FLAG-tagged ubiquitin and Cbl-G306E were starved and
mock-treated () or stimulated (+) with 50 ng/ml NGF for 60 min. (D) HEK293 cells
transfected with TrkA, ubiquitin and c-Cbl were pretreated with the tyrosine kinase
inhibitor K252a (100 nM) or mock-treated (0.1% DMSO) for 30 min before mock-
treatment () or stimulation (+) with 50 ng/ml NGF for the indicated times. After
20 min, the phosphorylation of TrkA and the blocking effect of K252a were
examined by Western blotting with antibodies against phospho-TrkA (p-TrkA)
(lower panel). After 60 min, degradation of TrkA and c-Cbl was analyzed byWestern
blotting (upper panel). Cell lysates were analyzed for TrkA, c-Cbl and b-actin levels
with speciﬁc antibodies. b-actin was used as a control for equal loading.
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NGF stimulation and are degraded in lysosomes (Fig. 4C and
Fig. 5). According to a previous report, it was suggested that c-
Cbl is not involved in TrkA ubiquitination and degradation [15].
Even though the effect of the c-Cbl-mediated degradation of TrkA
is smaller than that induced by Nedd4-2, our data show that c-
Cbl induces a statistically signiﬁcant effect on TrkA ubiquitination
and degradation. The TrkA tyrosine kinase domain contains a K547
residue and a Y785 residue that are both required for the proper
ubiquitination of TrkA by Nedd4-2 [15]. The domains of TrkA re-
quired for the ubiquitination by c-Cbl remain to be determined.
Additionally, degradation of several RTKs, such as EGF and HGF
(c-MET) receptors, also requires a ubiquitin-independent function
of c-Cbl in recruiting CIN85-endophilin complexes to activated
receptors [8,9]. It will be interesting to identify whether c-Cbl also
recruits CIN85-endophilin complexes following TrkA activation.
Regarding the internalization of TrkA, Arévalo et al. [15] re-
ported that the ubiquitination of TrkA by Nedd4-2 did not have a
strong impact on the internalization process. As shown in Fig. 3,
neither c-Cbl nor Nedd4-2 had an effect on TrkA internalization,
which is consistent with their observation. A mutated EGF receptor
that cannot be ubiquitinated was internalized normally following
EGF stimulation [25]. Similarly, deletion mutants of the EGF recep-
tor that are unable to recruit c-Cbl or Cbl-b (and thus fail to become
ubiquitinated) exhibit impaired intracellular degradation and
downregulation but are internalized normally [26]. Therefore,
ubiquitination is not necessary for internalization of at least TrkA
and the EGF receptor.
We can only speculate on the physiological signiﬁcance of
Cbl-mediated ubiquitination and degradation of TrkA. A recentreport has shown that TrkA undergoes NGF-induced ubiquitina-
tion, which is signiﬁcantly reduced in the presence of co-receptor,
p75 neurotrophin receptor (p75NTR) [27]. Takayama et al. [28] also
showed that LRP1 (low density lipoprotein receptor-related pro-
tein 1), a PDGF receptor co-receptor, reduces PDGF receptor ubiq-
uitination and extends the time that the PDGF receptor spends on
the cell surface. Furthermore, both p75NTR [29] and LRP1 [28]
interact with c-Cbl. Further studies are needed to clarify the func-
tional roles of c-Cbl and p75NTR and their possible cross-talk dur-
ing the downregulation of TrkA.
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